Clinical characteristics and risk factors for fatal outcome of patients receiving Sun's procedure after previous cardiac surgery

被引:3
|
作者
Sun, Guang-Long [1 ]
Sun, Li-Zhong [2 ]
Zhu, Jun-Ming [2 ]
Liu, Yong-Min [2 ]
Ge, Yi-Peng [2 ]
Xu, Shi-Jun [2 ]
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiovasc Surg, Beijing 100029, Peoples R China
[2] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing Aort Dis Ctr,Dept Cardiovasc Surg, 2 Anzhen Rd, Beijing 100029, Peoples R China
关键词
Sun's procedure; Clinical characteristic; Risk factors; Survival analysis; TETRAFURCATE GRAFT; THORACIC AORTA; REOPERATIONS; MORTALITY; OPERATION; ROOT;
D O I
10.1016/j.asjsur.2020.03.014
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Cardiac reoperation has always been a difficult problem in clinical practice. Because of the difficulty of operation, the incidence of complications and mortality rate is high. Secondary aortic surgery, especially the reoperation involving arch, has higher risk and is more difficult for patients with renal failure. Sun's operation (total arch replacement thorn stent elephant nose) has achieved good results in the treatment of diseases involving aortic arch, and occupies an important position in the treatment of patients with secondary arch lesions after cardiac surgery. Methods: A total of 395 patients with a history of cardiac surgery were recorded in our center from January 1, 2009 to December 31, 2017, among whom 118 (30.1%) patients underwent aortic reoperation via the original incision using Sun's aortic procedure owing to postoperative great vessel disease. We analyzed the clinical data and survival time, and used Cox regression to analyze the risk factors for 30-day mortality as well as long term mortality. Results: The interval between the last operation and the present operation was 0.08-19 years. Sixteen patients died within 30 days after operation and the average mortality rate was 13.6%. During the follow-up period, 28 patients died, with the mortality rate of 23.7%. As of December 31, 2017, the longest survival time was 9.36 years, and the survival time of 70 patients was more than 3.05 years. The main risk factor associated with the 30-day survival was cardiopulmonary bypass (CPB) time. The longer the CPB time was, the greater the risk of death was. The main risk factors associated with the long-term survival were CPB time and 24-h bleeding volume. The longer the CPB time was, the more the 24-h bleeding volume was, the higher long-term mortality rate was. Conclusion: The second Sun's operation, as a surgical treatment after cardiac surgery, showed a high survival rate, with long survival time and good curative effect. CPB is the main risk factor for the 30-day survival state after operation, and CPB time and 24-h bleeding volume are the main risk factors for the long-term survival state after operation. (C) 2020 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V.Y
引用
收藏
页码:87 / 92
页数:6
相关论文
共 50 条
  • [41] Clinical characteristics of and risk factors for secondary bloodstream infection after pneumonia among patients infected with methicillin-resistant Staphylococcus aureus
    Huang, Fangfang
    Shen, Ting
    Hai, Xin
    Xiu, Huiqing
    Zhang, Kai
    Huang, Tiancha
    Chen, Juan
    Guan, Zhihui
    Zhou, Hongwei
    Cai, Jiachang
    Cai, Zhijian
    Cui, Wei
    Zhang, Shufang
    Zhang, Gensheng
    HELIYON, 2022, 8 (12)
  • [42] Clinical pretreatment risk factors and prediction of outcome using gallium 67 scintigraphy in patients with Hodgkin's lymphoma
    Garcia Escobar, Ignacio
    Lopez, Ana
    Rubio, Judit
    Perez-Callejo, David
    Caballero Barrigon, Dolores
    Tamayo Alonso, Pilar
    Almagro Casado, Elena
    Provencio Pulla, Mariano
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (01) : 93 - 99
  • [43] Clinical characteristics, risk factors and outcome of severe Norovirus infection in kidney transplant patients: a case-control study
    Julien Gras
    Moustafa Abdel-Nabey
    Axelle Dupont
    Jérôme Le Goff
    Jean-Michel Molina
    Marie Noëlle Peraldi
    BMC Infectious Diseases, 21
  • [44] Risk factors and outcomes of myocardial injury after non-cardiac surgery in high-risk patients who underwent radical cystectomy
    Yu, Jihion
    Lim, Bumjin
    Lee, Yongsoo
    Park, Jun-Young
    Hong, Bumsik
    Hwang, Jai-Hyun
    Kim, Young-Kug
    MEDICINE, 2020, 99 (43)
  • [45] Perioperative Results and Risk Factors for In-Hospital Mortality In Patients With Stanford Type A Aortic Dissection Undergoing Sun's Procedure - A Single Center Study
    Wu, Yuhui
    Jiang, Rui
    Xu, Ping
    Wang, Guanrong
    Wang, Jianhua
    Yang, Sumin
    HEART SURGERY FORUM, 2018, 21 (06) : E432 - E437
  • [46] Re: Myocardial Injury After Noncardiac Surgery: Incidence, Predictive Factors, and Outcome in High-Risk Patients Undergoing Thoracic Surgery: An Observational Study
    Arslani, Ketina
    Puelacher, Christian
    Gualandro, Danielle Menosi
    Mueller, Christian
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2020, 34 (09) : 2549 - 2550
  • [47] Very early postoperative troponin increase and clinical outcome in patients admitted to the recovery room after noncardiac surgery with suspected cardiac events
    Conti, Duccio
    Ballo, Piercarlo
    Ruggiano, Peggy
    Boccalini, Rossana
    Pavoni, Vittorio
    Sarti, Armando
    INDIAN HEART JOURNAL, 2020, 72 (03) : 197 - 199
  • [48] Incidence, indications, risk factors, and survival of patients undergoing cardiac implantable electronic device implantation after open heart surgery
    Wiggins, Newton B.
    Chong, Daniel T.
    Houghtaling, Penny L.
    Hussein, Ayman A.
    Saliba, Walid
    Sabik, Joseph F.
    Wazni, Oussama
    Wilkoff, Bruce L.
    Tarakji, Khaldoun G.
    EUROPACE, 2017, 19 (08): : 1335 - 1342
  • [49] Polymorphisms in glutathione S-transferase are risk factors for perioperative acute myocardial infarction after cardiac surgery: a preliminary study
    Kovacs, Viktoria
    Gasz, Balazs
    Balatonyi, Borbala
    Jaromi, Luca
    Kisfali, Peter
    Borsiczky, Balazs
    Jancso, Gabor
    Marczin, Nandor
    Szabados, Sandor
    Melegh, Bela
    Nasri, Alotti
    Roth, Elisabeth
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2014, 389 (1-2) : 79 - 84
  • [50] Incidence, Risk Factors, and Outcome of Cytomegalovirus Infection and Disease in Patients Receiving Prophylaxis with Oral Valganciclovir or Intravenous Ganciclovir after Umbilical Cord Blood Transplantation
    Montesinos, Pau
    Sanz, Jaime
    Cantero, Susana
    Lorenzo, Ignacio
    Martin, Guillermo
    Saavedra, Silvana
    Palau, Javier
    Romero, Monica
    Montava, Alberto
    Senent, Leonor
    Martinez, Jesus
    Jarque, Isidro
    Salavert, Miguel
    Cordoba, Juan
    Gomez, Lola
    Weiss, Shirley
    Moscardo, Federico
    de la Rubia, Javier
    Larrea, Luis
    Sanz, Miguel A.
    Sanz, Guillermo F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (06) : 730 - 740